An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient.
Adult
Cystitis
/ diagnosis
Diagnosis, Differential
Female
Herpesviridae Infections
/ diagnosis
Herpesvirus 8, Human
/ pathogenicity
Humans
Immunocompromised Host
Immunosuppression Therapy
/ adverse effects
Kidney Transplantation
/ adverse effects
Lymphadenopathy
/ virology
Sarcoma, Kaposi
/ diagnosis
Transplant Recipients
Urinary Bladder
/ pathology
Immunosuppression
Kaposi sarcoma
human herpes virus-8
kidney transplantation
lymphadenopathy
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
07
02
2019
revised:
28
05
2019
accepted:
09
06
2019
pubmed:
21
6
2019
medline:
27
2
2020
entrez:
21
6
2019
Statut:
ppublish
Résumé
Human Herpes Virus-8 (HHV-8) may reactivate in immunocompromised patients including recipients of solid organ transplants. Reactivation of HHV-8 may result in Kaposi sarcoma (KS). KS typically occurs with dermatologic involvement but can affect virtually any other organ; most commonly the gastrointestinal tract. We present a diagnostically challenging case of KS in a South American woman 7 months after kidney transplant. She presented with recurrent urinary tract infection manifested by pelvic pain and dysuria. Imaging studies revealed bladder thickening with pelvic lymphadenopathy. Findings on tissue biopsied from the bladder and lymph nodes were consistent with KS. Her skin was not affected. This case illustrates that KS and other HHV-8-related diseases should be on the differential diagnosis as a cause of mass lesions as well as lymphadenopathy in transplant recipients. The case exemplifies the need to pursue a tissue diagnosis in immunocompromised patients when a diagnosis is uncertain.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13132Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Razonable RR. Human herpesviruses 6, 7 and 8 in Solid organ transplant recipients. Am J Transplant. 2013;13 (S3):67-77. quiz 77-8.
Lebbe C, Legendre C, Frances C. Kaposi sarcoma in transplantation. Transplant Rev (Orlando). 2008;22(4):252-261.
Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L. How I treat HHV8/KSHV-related diseases in posttransplant patients. Blood. 2012;120(20):4150-4159.
Campistol JM, Schena FP. Kaposi's sarcoma in renal transplant recipients-the impact of proliferation signal inhibitors. Nephrol Dial Transplant. 2007;22(Suppl 1):i17-i22.
Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, Rotstein C, Husain S. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012;14(4):338-345.
Cahoon EK, Linet MS, Clarke CA, Pawlish KS, Engels EA, Pfeiffer RM. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer. 2018;143(11):2741-2748.
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681-1691.
Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):1317-1323.
Barete S, Calvez V, Mouquet C, et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol. 2000;136(12):1452-1458.
Fu W, Merola J, Malinis M, et al. Successful treatment of primary donor-derived human herpesvirus-8 infection and hepatic Kaposi sarcoma in an adult liver transplant recipient. Transpl Infect Dis. 2018;20(5):e12966.
Abbaszadeh S, Taheri S. Kaposi's sarcoma after renal transplantation. Saudi J Kidney Dis Transpl. 2009;20(5):775-778.
Pantanowitz L, Dezube BJ. Kaposi sarcoma in unusual locations. BMC Cancer. 2008;8:190.
Lee J, Jeon H, Yoo S-M, Park J, Lee M-S. The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells. Tumour Biol. 2016;37(2):2587-2596.
Lebbe C, Porcher R, Marcelin AG, et al. Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant. 2013;13(1):207-213.
Yaich S, Charfeddine K, Zaghdane S, et al. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases. Transplant Proc. 2012;44(9):2824-2826.
Lebbe C, Euvrard S, Barrou B, et al. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant. 2006;6(9):2164-2168.